ENTITY

Lifecore Biomedical (LFCR US)

4
Analysis
Consumer StaplesUnited States
Lifecore Biomedical, Inc. operates as a contract development and manufacturing company. The Company offers sterile injectable pharmaceutical products in syringes and vials as well as the manufactures pharmaceutical-grade sodium hyaluronate. Lifecore Biomedical serves customers worldwide.
more
bearishBenson Hill
25 Nov 2024 11:12

Event-Driven Updates: BHIL's Widening Spread, MSTR's Short-Seller Impact

Benson Hill's share price decline amid no management updates raises concerns of potential buyout failure and urgent funding needs.

Share
bullishGalaxy Gaming
18 Nov 2024 11:53

SSI Weekly: Galaxy Gaming Acquisition and Other Portfolio Updates

Galaxy Gaming is being acquired by Evolution AB for $3.20/share, with a 17% spread and minimal regulatory hurdles. Other updates follow.

Share
bullishAvation PLC
11 Nov 2024 09:56

Key Updates on EPIX, HLVX, PRKR, BOOM, VZIO, WOW, AVAP:L, LOGC, LFCR, DK

Essa Pharma (EPIX) halted pipeline development, launched strategic review, offering 21% upside to NAV/liquidation value by mid-2025.

Share
27 Sep 2022 15:12Syndicated

Summers Value Partners Q2 2022 Investor Letter

Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers...

Logo
184 Views
Share
No more insights
x